img

Global Calcium Antagonists Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Calcium Antagonists Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Calcium antagonists are a group of medications that disrupt the movement of calcium (Ca2+) through calcium channels. Calcium channel blockers are used as antihypertensive drugs, i.e., as medications to decrease blood pressure in patients with hypertension. CCBs are particularly effective against large vessel stiffness, one of the common causes of elevated systolic blood pressure in elderly patients. Calcium channel blockers are also frequently used to alter heart rate (especially from atrial fibrillation), to prevent peripheral and cerebral vasospasm, and to reduce chest pain caused by angina pectoris.

N-type, L-type, and T-type voltage-dependent calcium channels are present in the zona glomerulosa of the human adrenal gland, and CCBs can directly influence the biosynthesis of aldosterone in adrenocortical cells, with consequent impact on the clinical treatment of hypertension with these agents.

CCBs have been shown to be slightly more effective than beta blockers at lowering cardiovascular mortality, but they are associated with more side effects. Potential major risks however were mainly found to be associated with short-acting CCBs.
Calcium Antagonists report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Calcium Antagonists market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hypertension and Coronary Artery Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Calcium Antagonists industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Calcium Antagonists key manufacturers include Pfizer, Aventis, Searle, Bayer, AstraZeneca, Knoll Pharmaceuticals, Wyeth-Ayerst, Novartis and Sanofi, etc. Pfizer, Aventis, Searle are top 3 players and held % sales share in total in 2022.
Calcium Antagonists can be divided into Dihydropyridine, Diltiazem, Verapamil and Others, etc. Dihydropyridine is the mainstream product in the market, accounting for % sales share globally in 2022.
Calcium Antagonists is widely used in various fields, such as Hypertension, Coronary Artery Disease, Arrhythmia and Ohers, etc. Hypertension provides greatest supports to the Calcium Antagonists industry development. In 2022, global % sales of Calcium Antagonists went into Hypertension filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Calcium Antagonists market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
Novartis
Sanofi
Baiyunshan Pharmaceutical
South China Pharmaceutical Group
Tianjin Tanabe Seiyaku
Segment by Type
Dihydropyridine
Diltiazem
Verapamil
Others

Segment by Application


Hypertension
Coronary Artery Disease
Arrhythmia
Ohers

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Calcium Antagonists market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Calcium Antagonists, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Calcium Antagonists industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Calcium Antagonists in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Calcium Antagonists introduction, etc. Calcium Antagonists Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Calcium Antagonists market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Calcium Antagonists Market Overview
1.1 Calcium Antagonists Product Overview
1.2 Calcium Antagonists Market Segment by Type
1.2.1 Dihydropyridine
1.2.2 Diltiazem
1.2.3 Verapamil
1.2.4 Others
1.3 Global Calcium Antagonists Market Size by Type
1.3.1 Global Calcium Antagonists Market Size Overview by Type (2024-2034)
1.3.2 Global Calcium Antagonists Historic Market Size Review by Type (2024-2024)
1.3.3 Global Calcium Antagonists Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Calcium Antagonists Sales Breakdown by Type (2024-2024)
1.4.2 Europe Calcium Antagonists Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Calcium Antagonists Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Calcium Antagonists Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Calcium Antagonists Sales Breakdown by Type (2024-2024)
2 Global Calcium Antagonists Market Competition by Company
2.1 Global Top Players by Calcium Antagonists Sales (2024-2024)
2.2 Global Top Players by Calcium Antagonists Revenue (2024-2024)
2.3 Global Top Players by Calcium Antagonists Price (2024-2024)
2.4 Global Top Manufacturers Calcium Antagonists Manufacturing Base Distribution, Sales Area, Product Type
2.5 Calcium Antagonists Market Competitive Situation and Trends
2.5.1 Calcium Antagonists Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Calcium Antagonists Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Calcium Antagonists as of 2022)
2.7 Date of Key Manufacturers Enter into Calcium Antagonists Market
2.8 Key Manufacturers Calcium Antagonists Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Calcium Antagonists Status and Outlook by Region
3.1 Global Calcium Antagonists Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Calcium Antagonists Historic Market Size by Region
3.2.1 Global Calcium Antagonists Sales in Volume by Region (2024-2024)
3.2.2 Global Calcium Antagonists Sales in Value by Region (2024-2024)
3.2.3 Global Calcium Antagonists Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Calcium Antagonists Forecasted Market Size by Region
3.3.1 Global Calcium Antagonists Sales in Volume by Region (2024-2034)
3.3.2 Global Calcium Antagonists Sales in Value by Region (2024-2034)
3.3.3 Global Calcium Antagonists Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Calcium Antagonists by Application
4.1 Calcium Antagonists Market Segment by Application
4.1.1 Hypertension
4.1.2 Coronary Artery Disease
4.1.3 Arrhythmia
4.1.4 Ohers
4.2 Global Calcium Antagonists Market Size by Application
4.2.1 Global Calcium Antagonists Market Size Overview by Application (2024-2034)
4.2.2 Global Calcium Antagonists Historic Market Size Review by Application (2024-2024)
4.2.3 Global Calcium Antagonists Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Calcium Antagonists Sales Breakdown by Application (2024-2024)
4.3.2 Europe Calcium Antagonists Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Calcium Antagonists Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Calcium Antagonists Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Calcium Antagonists Sales Breakdown by Application (2024-2024)
5 North America Calcium Antagonists by Country
5.1 North America Calcium Antagonists Historic Market Size by Country
5.1.1 North America Calcium Antagonists Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Calcium Antagonists Sales in Volume by Country (2024-2024)
5.1.3 North America Calcium Antagonists Sales in Value by Country (2024-2024)
5.2 North America Calcium Antagonists Forecasted Market Size by Country
5.2.1 North America Calcium Antagonists Sales in Volume by Country (2024-2034)
5.2.2 North America Calcium Antagonists Sales in Value by Country (2024-2034)
6 Europe Calcium Antagonists by Country
6.1 Europe Calcium Antagonists Historic Market Size by Country
6.1.1 Europe Calcium Antagonists Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Calcium Antagonists Sales in Volume by Country (2024-2024)
6.1.3 Europe Calcium Antagonists Sales in Value by Country (2024-2024)
6.2 Europe Calcium Antagonists Forecasted Market Size by Country
6.2.1 Europe Calcium Antagonists Sales in Volume by Country (2024-2034)
6.2.2 Europe Calcium Antagonists Sales in Value by Country (2024-2034)
7 Asia-Pacific Calcium Antagonists by Region
7.1 Asia-Pacific Calcium Antagonists Historic Market Size by Region
7.1.1 Asia-Pacific Calcium Antagonists Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Calcium Antagonists Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Calcium Antagonists Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Calcium Antagonists Forecasted Market Size by Region
7.2.1 Asia-Pacific Calcium Antagonists Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Calcium Antagonists Sales in Value by Region (2024-2034)
8 Latin America Calcium Antagonists by Country
8.1 Latin America Calcium Antagonists Historic Market Size by Country
8.1.1 Latin America Calcium Antagonists Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Calcium Antagonists Sales in Volume by Country (2024-2024)
8.1.3 Latin America Calcium Antagonists Sales in Value by Country (2024-2024)
8.2 Latin America Calcium Antagonists Forecasted Market Size by Country
8.2.1 Latin America Calcium Antagonists Sales in Volume by Country (2024-2034)
8.2.2 Latin America Calcium Antagonists Sales in Value by Country (2024-2034)
9 Middle East and Africa Calcium Antagonists by Country
9.1 Middle East and Africa Calcium Antagonists Historic Market Size by Country
9.1.1 Middle East and Africa Calcium Antagonists Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Calcium Antagonists Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Calcium Antagonists Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Calcium Antagonists Forecasted Market Size by Country
9.2.1 Middle East and Africa Calcium Antagonists Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Calcium Antagonists Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Calcium Antagonists Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Pfizer Calcium Antagonists Products Offered
10.1.5 Pfizer Recent Development
10.2 Aventis
10.2.1 Aventis Company Information
10.2.2 Aventis Introduction and Business Overview
10.2.3 Aventis Calcium Antagonists Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Aventis Calcium Antagonists Products Offered
10.2.5 Aventis Recent Development
10.3 Searle
10.3.1 Searle Company Information
10.3.2 Searle Introduction and Business Overview
10.3.3 Searle Calcium Antagonists Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Searle Calcium Antagonists Products Offered
10.3.5 Searle Recent Development
10.4 Bayer
10.4.1 Bayer Company Information
10.4.2 Bayer Introduction and Business Overview
10.4.3 Bayer Calcium Antagonists Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Bayer Calcium Antagonists Products Offered
10.4.5 Bayer Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Introduction and Business Overview
10.5.3 AstraZeneca Calcium Antagonists Sales, Revenue and Gross Margin (2024-2024)
10.5.4 AstraZeneca Calcium Antagonists Products Offered
10.5.5 AstraZeneca Recent Development
10.6 Knoll Pharmaceuticals
10.6.1 Knoll Pharmaceuticals Company Information
10.6.2 Knoll Pharmaceuticals Introduction and Business Overview
10.6.3 Knoll Pharmaceuticals Calcium Antagonists Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Knoll Pharmaceuticals Calcium Antagonists Products Offered
10.6.5 Knoll Pharmaceuticals Recent Development
10.7 Wyeth-Ayerst
10.7.1 Wyeth-Ayerst Company Information
10.7.2 Wyeth-Ayerst Introduction and Business Overview
10.7.3 Wyeth-Ayerst Calcium Antagonists Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Wyeth-Ayerst Calcium Antagonists Products Offered
10.7.5 Wyeth-Ayerst Recent Development
10.8 Novartis
10.8.1 Novartis Company Information
10.8.2 Novartis Introduction and Business Overview
10.8.3 Novartis Calcium Antagonists Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Novartis Calcium Antagonists Products Offered
10.8.5 Novartis Recent Development
10.9 Sanofi
10.9.1 Sanofi Company Information
10.9.2 Sanofi Introduction and Business Overview
10.9.3 Sanofi Calcium Antagonists Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Sanofi Calcium Antagonists Products Offered
10.9.5 Sanofi Recent Development
10.10 Baiyunshan Pharmaceutical
10.10.1 Baiyunshan Pharmaceutical Company Information
10.10.2 Baiyunshan Pharmaceutical Introduction and Business Overview
10.10.3 Baiyunshan Pharmaceutical Calcium Antagonists Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Baiyunshan Pharmaceutical Calcium Antagonists Products Offered
10.10.5 Baiyunshan Pharmaceutical Recent Development
10.11 South China Pharmaceutical Group
10.11.1 South China Pharmaceutical Group Company Information
10.11.2 South China Pharmaceutical Group Introduction and Business Overview
10.11.3 South China Pharmaceutical Group Calcium Antagonists Sales, Revenue and Gross Margin (2024-2024)
10.11.4 South China Pharmaceutical Group Calcium Antagonists Products Offered
10.11.5 South China Pharmaceutical Group Recent Development
10.12 Tianjin Tanabe Seiyaku
10.12.1 Tianjin Tanabe Seiyaku Company Information
10.12.2 Tianjin Tanabe Seiyaku Introduction and Business Overview
10.12.3 Tianjin Tanabe Seiyaku Calcium Antagonists Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Tianjin Tanabe Seiyaku Calcium Antagonists Products Offered
10.12.5 Tianjin Tanabe Seiyaku Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Calcium Antagonists Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Calcium Antagonists Industrial Chain Analysis
11.4 Calcium Antagonists Market Dynamics
11.4.1 Calcium Antagonists Industry Trends
11.4.2 Calcium Antagonists Market Drivers
11.4.3 Calcium Antagonists Market Challenges
11.4.4 Calcium Antagonists Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Calcium Antagonists Distributors
12.3 Calcium Antagonists Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Dihydropyridine
Table 2. Major Company of Diltiazem
Table 3. Major Company of Verapamil
Table 4. Major Company of Others
Table 5. Global Calcium Antagonists Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Calcium Antagonists Sales by Type (2024-2024) & (K Units)
Table 7. Global Calcium Antagonists Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Calcium Antagonists Sales by Type (2024-2024) & (US& Million)
Table 9. Global Calcium Antagonists Market Share in Value by Type (2024-2024)
Table 10. Global Calcium Antagonists Price by Type (2024-2024) & (USD/Unit)
Table 11. Global Calcium Antagonists Sales by Type (2024-2034) & (K Units)
Table 12. Global Calcium Antagonists Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Calcium Antagonists Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Calcium Antagonists Sales Market Share in Value by Type (2024-2034)
Table 15. Global Calcium Antagonists Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Calcium Antagonists Sales by Type (2024-2024) & (K Units)
Table 17. North America Calcium Antagonists Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Calcium Antagonists Sales (K Units) by Type (2024-2024)
Table 19. Europe Calcium Antagonists Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Calcium Antagonists Sales (K Units) by Type (2024-2024)
Table 21. Asia-Pacific Calcium Antagonists Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Calcium Antagonists Sales (K Units) by Type (2024-2024)
Table 23. Latin America Calcium Antagonists Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Calcium Antagonists Sales (K Units) by Type (2024-2024)
Table 25. Middle East and Africa Calcium Antagonists Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Calcium Antagonists Sales by Company (2024-2024) & (K Units)
Table 27. Global Calcium Antagonists Sales Share by Company (2024-2024)
Table 28. Global Calcium Antagonists Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Calcium Antagonists Revenue Share by Company (2024-2024)
Table 30. Global Market Calcium Antagonists Price by Company (2024-2024) & (USD/Unit)
Table 31. Global Calcium Antagonists Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Calcium Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Calcium Antagonists as of 2022)
Table 34. Date of Key Manufacturers Enter into Calcium Antagonists Market
Table 35. Key Manufacturers Calcium Antagonists Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Calcium Antagonists Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Calcium Antagonists Sales by Region (2024-2024) & (K Units)
Table 39. Global Calcium Antagonists Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Calcium Antagonists Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Calcium Antagonists Sales Market Share in Value by Region (2024-2024)
Table 42. Global Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 43. Global Calcium Antagonists Sales by Region (2024-2034) & (K Units)
Table 44. Global Calcium Antagonists Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Calcium Antagonists Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Calcium Antagonists Sales Market Share in Value by Region (2024-2034)
Table 47. Global Calcium Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Calcium Antagonists Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Calcium Antagonists Sales by Application (2024-2024) & (K Units)
Table 50. Global Calcium Antagonists Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Calcium Antagonists Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Calcium Antagonists Sales Market Share in Value by Application (2024-2024)
Table 53. Global Calcium Antagonists Price by Application (2024-2024) & (USD/Unit)
Table 54. Global Calcium Antagonists Sales by Application (2024-2034) & (K Units)
Table 55. Global Calcium Antagonists Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Calcium Antagonists Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Calcium Antagonists Sales Market Share in Value by Application (2024-2034)
Table 58. Global Calcium Antagonists Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Calcium Antagonists Sales by Application (2024-2024) (K Units)
Table 60. North America Calcium Antagonists Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Calcium Antagonists Sales by Application (2024-2024) (K Units)
Table 62. Europe Calcium Antagonists Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Calcium Antagonists Sales by Application (2024-2024) (K Units)
Table 64. Asia-Pacific Calcium Antagonists Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Calcium Antagonists Sales by Application (2024-2024) (K Units)
Table 66. Latin America Calcium Antagonists Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Calcium Antagonists Sales by Application (2024-2024) (K Units)
Table 68. Middle East and Africa Calcium Antagonists Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Calcium Antagonists Sales by Country (2024-2024) & (K Units)
Table 70. North America Calcium Antagonists Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Calcium Antagonists Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Calcium Antagonists Sales Market Share in Value by Country (2024-2024)
Table 73. North America Calcium Antagonists Sales by Country (2024-2034) & (K Units)
Table 74. North America Calcium Antagonists Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Calcium Antagonists Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Calcium Antagonists Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Calcium Antagonists Sales by Country (2024-2024) & (K Units)
Table 78. Europe Calcium Antagonists Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Calcium Antagonists Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Calcium Antagonists Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Calcium Antagonists Sales by Country (2024-2034) & (K Units)
Table 82. Europe Calcium Antagonists Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Calcium Antagonists Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Calcium Antagonists Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Calcium Antagonists Sales by Region (2024-2024) & (K Units)
Table 86. Asia-Pacific Calcium Antagonists Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Calcium Antagonists Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Calcium Antagonists Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Calcium Antagonists Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Calcium Antagonists Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Calcium Antagonists Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Calcium Antagonists Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Calcium Antagonists Sales by Country (2024-2024) & (K Units)
Table 94. Latin America Calcium Antagonists Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Calcium Antagonists Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Calcium Antagonists Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Calcium Antagonists Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Calcium Antagonists Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Calcium Antagonists Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Calcium Antagonists Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Calcium Antagonists Sales by Country (2024-2024) & (K Units)
Table 102. Middle East and Africa Calcium Antagonists Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Calcium Antagonists Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Calcium Antagonists Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Calcium Antagonists Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Calcium Antagonists Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Calcium Antagonists Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Calcium Antagonists Sales Market Share in Value by Country (2024-2034)
Table 109. Pfizer Company Information
Table 110. Pfizer Introduction and Business Overview
Table 111. Pfizer Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 112. Pfizer Calcium Antagonists Product
Table 113. Pfizer Recent Development
Table 114. Aventis Company Information
Table 115. Aventis Introduction and Business Overview
Table 116. Aventis Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 117. Aventis Calcium Antagonists Product
Table 118. Aventis Recent Development
Table 119. Searle Company Information
Table 120. Searle Introduction and Business Overview
Table 121. Searle Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 122. Searle Calcium Antagonists Product
Table 123. Searle Recent Development
Table 124. Bayer Company Information
Table 125. Bayer Introduction and Business Overview
Table 126. Bayer Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 127. Bayer Calcium Antagonists Product
Table 128. Bayer Recent Development
Table 129. AstraZeneca Company Information
Table 130. AstraZeneca Introduction and Business Overview
Table 131. AstraZeneca Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 132. AstraZeneca Calcium Antagonists Product
Table 133. AstraZeneca Recent Development
Table 134. Knoll Pharmaceuticals Company Information
Table 135. Knoll Pharmaceuticals Introduction and Business Overview
Table 136. Knoll Pharmaceuticals Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 137. Knoll Pharmaceuticals Calcium Antagonists Product
Table 138. Knoll Pharmaceuticals Recent Development
Table 139. Wyeth-Ayerst Company Information
Table 140. Wyeth-Ayerst Introduction and Business Overview
Table 141. Wyeth-Ayerst Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 142. Wyeth-Ayerst Calcium Antagonists Product
Table 143. Wyeth-Ayerst Recent Development
Table 144. Novartis Company Information
Table 145. Novartis Introduction and Business Overview
Table 146. Novartis Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 147. Novartis Calcium Antagonists Product
Table 148. Novartis Recent Development
Table 149. Sanofi Company Information
Table 150. Sanofi Introduction and Business Overview
Table 151. Sanofi Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 152. Sanofi Calcium Antagonists Product
Table 153. Sanofi Recent Development
Table 154. Baiyunshan Pharmaceutical Company Information
Table 155. Baiyunshan Pharmaceutical Introduction and Business Overview
Table 156. Baiyunshan Pharmaceutical Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 157. Baiyunshan Pharmaceutical Calcium Antagonists Product
Table 158. Baiyunshan Pharmaceutical Recent Development
Table 159. South China Pharmaceutical Group Company Information
Table 160. South China Pharmaceutical Group Introduction and Business Overview
Table 161. South China Pharmaceutical Group Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 162. South China Pharmaceutical Group Calcium Antagonists Product
Table 163. South China Pharmaceutical Group Recent Development
Table 164. Tianjin Tanabe Seiyaku Company Information
Table 165. Tianjin Tanabe Seiyaku Introduction and Business Overview
Table 166. Tianjin Tanabe Seiyaku Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 167. Tianjin Tanabe Seiyaku Calcium Antagonists Product
Table 168. Tianjin Tanabe Seiyaku Recent Development
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. Calcium Antagonists Market Trends
Table 172. Calcium Antagonists Market Drivers
Table 173. Calcium Antagonists Market Challenges
Table 174. Calcium Antagonists Market Restraints
Table 175. Calcium Antagonists Distributors List
Table 176. Calcium Antagonists Downstream Customers
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Calcium Antagonists Product Picture
Figure 2. Global Calcium Antagonists Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Calcium Antagonists Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Calcium Antagonists Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Dihydropyridine
Figure 6. Global Dihydropyridine Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Diltiazem
Figure 8. Global Diltiazem Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Verapamil
Figure 10. Global Verapamil Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Global Calcium Antagonists Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Calcium Antagonists Sales Market Share by Type in 2022 & 2034
Figure 15. North America Calcium Antagonists Sales Market Share in Volume by Type in 2022
Figure 16. North America Calcium Antagonists Sales Market Share in Value by Type in 2022
Figure 17. Europe Calcium Antagonists Sales Market Share in Volume by Type in 2022
Figure 18. Europe Calcium Antagonists Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Calcium Antagonists Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Calcium Antagonists Sales Market Share in Value by Type in 2022
Figure 21. Latin America Calcium Antagonists Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Calcium Antagonists Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Calcium Antagonists Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Calcium Antagonists Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Calcium Antagonists Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Calcium Antagonists Revenue in 2022
Figure 27. Calcium Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Hypertension
Figure 29. Global Hypertension Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Coronary Artery Disease
Figure 31. Global Coronary Artery Disease Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Arrhythmia
Figure 33. Global Arrhythmia Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of Ohers
Figure 35. Global Ohers Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Global Calcium Antagonists Sales by Application (2024-2034) & (US$ Million)
Figure 37. Global Calcium Antagonists Sales Market Share by Application in 2022 & 2034
Figure 38. North America Calcium Antagonists Sales Market Share in Volume by Application in 2022
Figure 39. North America Calcium Antagonists Sales Market Share in Value by Application in 2022
Figure 40. Europe Calcium Antagonists Sales Market Share in Volume by Application in 2022
Figure 41. Europe Calcium Antagonists Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Calcium Antagonists Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Calcium Antagonists Sales Market Share in Value by Application in 2022
Figure 44. Latin America Calcium Antagonists Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Calcium Antagonists Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Calcium Antagonists Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Calcium Antagonists Manufacturing Cost Structure
Figure 49. Calcium Antagonists Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed